510(k) K033007
K033007 is an FDA 510(k) premarket notification submitted by Bayer Diagnostics Corp. for the device "BAYER ADVIA DIGOXIN ASSAY FOR THE INTEGRATED MODULE SYSTEM". The FDA issued a decision of Substantially Equivalent on Nov 14, 2003. The device falls under product code KXT (Enzyme Immunoassay, Digoxin), a Class II device regulated under 21 CFR 862.3320. Bayer Diagnostics Corp. has 31 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Nov 14, 2003
- Date Received
- Sep 26, 2003
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzyme Immunoassay, Digoxin
- Device Class
- Class II
- Regulation Number
- 862.3320
- Review Panel
- TX
- Submission Type
- 510(k)
Need the full FDA record for Bayer Diagnostics Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.